Filing Flows

Filing Flows › Industrials › Kewaunee Scientific (KEQU)

Kewaunee Scientific (KEQU) earnings and revenue breakdown

Latest: Q1 FY27 · 10-Q filed Sep 11, 2026 · Kewaunee Scientific (KEQU) Q1 FY27 earnings results →

Q1 FY27 Revenue down 7% year over year to $66.3M · 3¢ of every $1 of revenue kept as net profit · operating margin 4.8%

Kewaunee Scientific made $66.3M in Q1 FY27 (-7% Y/Y). Operating margin 4.8%, net earnings $1.7M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Sep 11, 2026.

Revenue$66.3M
Year over year-7%
Operating margin4.8%
Net earnings$1.7M
Operating cash flow$2.0M

Drawing the Sankey…

Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF

What changed this quarter

Revenue was $66.3M in Q1 FY27, down 7% year over year and down 7% from the previous quarter.

Gross margin was 29.6%, up 0.2 points from Q1 FY26. Operating profit was $3.2M, a 4.8% margin (down 2.0 points year over year). Operating expenses grew 2% against a revenue fall of 7%. Net earnings were $1.7M, down 45% year over year. The effective tax rate was 28.0%.

Operating cash flow was $2.0M (down 66% year over year), 107% of net income including minority interests. Non-cash charges added back $1.6M of depreciation and $1.9M of share-based compensation. Working capital and other items used $3.4M. Capital expenditures of $772K left free cash flow of $1.2M.

Quarterly history

Kewaunee Scientific revenue by quarterKewaunee Scientific revenue by quarter$67.2MQ3 FY25$77.1MQ4 FY25$71.1MQ1 FY26$70.1MQ2 FY26$69.4MQ3 FY26$71.4MQ4 FY26$66.3MQ1 FY27
Kewaunee Scientific net earnings by quarterKewaunee Scientific net earnings by quarter$1.4MQ3 FY25$4.8MQ4 FY25$3.1MQ1 FY26$2.4MQ2 FY26$692KQ3 FY26$3.4MQ4 FY26$1.7MQ1 FY27
QuarterFormFiledRevenueY/YOp. marginNet earningsOp. cash flow
Q1 FY2710-QSep 11, 2026$66.3M-7%4.8%$1.7M$2.0M
Q4 FY2610-KJun 26, 2026$71.4M-8%7.3%$3.4M$5.5M
Q3 FY2610-QMar 13, 2026$69.4M+3%3.7%$692K$11.6M
Q2 FY2610-QDec 12, 2025$70.1M+47%5.9%$2.4M−$4.3M
Q1 FY2610-QSep 12, 2025$71.1M+47%6.8%$3.1M$5.8M
Q4 FY2510-KJul 2, 2025$77.1M+36%11.0%$4.8M$9.4M
Q3 FY2510-QMar 14, 2025$67.2M+44%3.3%$1.4M−$2.3M

Charts

Kewaunee Scientific: revenue growth, year over year and quarter over quarterKewaunee Scientific: revenue growth, year over year and quarter over quarterY/YQ/Q+44%Q3 FY25+36%+15%Q4 FY25+47%-8%Q1 FY26+47%-1%Q2 FY26+3%-1%Q3 FY26-8%+3%Q4 FY26-7%-7%Q1 FY27
Latest (Q1 FY27): Y/Y -7%, Q/Q -7%.
Kewaunee Scientific: where the cash came from (+) and went (−), TTM to Q1 FY27Kewaunee Scientific: where the cash came from (+) and went (−), TTM to Q1 FY27Other financing−$19.8MOperating cash flow$14.8MCash drawn (+) / kept (−)$10.2MCapital spending−$3.9MExchange rates−$698KBuybacks−$529KNet borrowing (+) / repaid (−)$11K
From the cash-flow statement as filed (SEC XBRL). Cash is fungible: the bars do not say which dollar paid for what.
Kewaunee Scientific: profit against cash, quarter by quarterKewaunee Scientific: profit against cash, quarter by quarterNet incomeOperating cash flow$3.0M$8.4MQ2 FY25$1.4M−$2.3MQ3 FY25$4.9M$9.4MQ4 FY25$3.2M$5.8MQ1 FY26$2.5M−$4.3MQ2 FY26$1.1M$11.6MQ3 FY26$3.7M$5.5MQ4 FY26$1.8M$2.0MQ1 FY27
Latest (Q1 FY27): Net income $1.8M, Operating cash flow $2.0M.
Kewaunee Scientific: diluted shares by fiscal yearKewaunee Scientific: diluted shares by fiscal year3MFY213MFY223MFY233MFY243MFY253MFY26
+8.1% since FY21: more shares outstanding (issuance, stock pay).

Interactive views

The same charts as the app — open one to draw it.

💵Where each $1 goesinteractive

Loading the interactive chart…

🌏Named in Asian annual reportsinteractive

Loading the interactive chart…

🔄Rotation against the market and its industry (RRG)interactive

Loading the interactive chart…

🔍Earnings qualityinteractive

Loading the interactive chart…

⚖️Fair value by methodinteractive

Loading the interactive chart…

🔭Outlook & guidanceinteractive

Loading the interactive chart…

📈Investments: gains and what it boughtinteractive

Loading the interactive chart…

🏭Its industry’s money flow (input-output)interactive

Loading the interactive chart…

About Kewaunee Scientific

Kewaunee Scientific Corporation (the "Company") was founded in 1906, incorporated in Michigan in 1941, became publicly-held in 1968, and was reincorporated in Delaware in 1970. Our principal business is the design, manufacture, and installation of laboratory, healthcare, and technical furniture and infrastructure products. Our products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. Our acquisition, discussed below, of Nu Aire, Inc. ("Nu Aire") complements Kewaunee Scientific's existing portfolio through Nu Aire's biological safety cabinets, CO2 incubators, ultralow freezers, and other essential laboratory products.

In its own words, from its annual report, filed Jul 2, 2025.

Source: Kewaunee Scientific 10-Q on SEC EDGAR · CIK 55529 · Laboratory Apparatus & Furniture

13F: who owns KEQU and who is buying

Largest holders of KEQU (13F)Largest holders of KEQU (13F)Northern Trust$8.5MDimensional Fund Advisors LP$6.2MMinerva Advisors LLC$5.3MVanguard Group$4.6MVanguard Capital Management LLC$3.9MPunch & Associates Investment Man…$3.7MRenaissance Technologies LLC$3.4MDe Lisle Partners LLP$1.9MRoyce & Associates LP$1.8MAmerican Century Companies$1.8M
Funds' net buying of KEQU by quarter (13F)Funds' net buying of KEQU by quarter (13F)−$973K2024-09−$465K2024-12−$2.9M2025-03−$2.6M2025-06$1.0M2025-09$1.7M2025-12$199K2026-03$436K2026-06
Value of shares 13F filers added minus the value they sold, each quarter (quarters with most filings in).

More on KEQU

History

Every quarter: Q1 FY27 results · Q4 FY26 results · Q3 FY26 results · Q2 FY26 results · Q1 FY26 results · Q4 FY25 results · Q3 FY25 results

中文版:Kewaunee Scientific(KEQU)财报

Español · Français